Alkylating agents: all 3,295 studies that test it
Page 28 of 33. Open to participants first (456), then studies with results posted, then the rest; newest registration first within each.
- Doxorubicin and Cyclophosphamide in Treating Older Women With Stage I, Stage II, or Stage III Breast Cancer That Has Been Removed By SurgeryCompletedNCT00424203Phase 2
- A Study of ADH-1 in Combination With Normothermic Isolated Limb Infusion of MelphalanCompletedNCT00421811Phase 1/2
- Metronomic Chemotherapy by Cyclophosphamide Versus Megestrol in Palliative CancerCompletedNCT00420563Phase 2
- Temozolomide in Association With Topotecan in Refractory or Relapsed Malignant Tumors in Children and AdolescentsCompletedNCT00412503Phase 1
- Gemcitabine Plus Busulfan, Melphalan and Hematopoietic Cell Transplant for Advanced Lymphoid MalignanciesCompletedNCT00410982Phase 1
- Abraxane and Temodar Plus Genasense in Advanced MelanomaStatus unknownNCT00409383Phase 1
- Stem Cell Transplant in Sickle Cell Disease and ThalassemiaActive, not recruitingNCT00408447Phase 2
- Alloreactive NK Cells for Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)CompletedNCT00402558Phase 1
- Docetaxel and Temozolomide in Treating Patients With Metastatic CancerCompletedNCT00401180Phase 1
- Temozolomide in Treating Patients With Newly Diagnosed Anaplastic Oligodendroglioma or Mixed OligoastrocytomaCompletedNCT00400816Phase 2
- Combination Chemotherapy in Treating Young Male Patients With Hodgkin's LymphomaCompletedNCT00398554Phase 2
- Docetaxel, Epirubicin, and Cyclophosphamide With or Without Trastuzumab in Treating Women With Locally Advanced Breast Cancer That Can Be Removed By SurgeryStatus unknownNCT00398489Phase 2
- Rituximab, Fludarabine, Cyclophosphamide, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Relapsed B-Cell Non-Hodgkin's LymphomaStatus unknownNCT00397800Phase 1/2
- Elimination of CD4+CD25+ Regulatory T Cells in Patients With Hepatocellular CarcinomaCompletedNCT00396682Phase 3
- AQ4N in Combination With Radiotherapy and Temozolomide in Subjects With Newly Diagnosed Glioblastoma MultiformeStatus unknownNCT00394628Phase 1/2
- Combination Chemotherapy With or Without Etoposide Followed By an Autologous Stem Cell Transplant in Treating Young Patients With Previously Untreated Malignant Brain TumorsStatus unknownNCT00392886Phase 3
- Melphalan, Yttrium Y 90 Ibritumomab Tiuxetan, and Rituximab Followed by Autologous Stem Cell Transplant in Treating Older Patients With Non-Hodgkin's Lymphoma That Has Relapsed or Not Responded to Previous TreatmentCompletedNCT00392691Phase 1
- Gossypol (AT-101) and Temozolomide With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma MultiformeCompletedNCT00390403Phase 1
- Imatinib, Bevacizumab, and Cyclophosphamide in Patients With Refractory Metastatic Solid TumorsCompletedNCT00390156Phase 1
- Fludarabine and Cyclophosphamide Followed By LMB-2 Immunotoxin in Treating Patients With Hodgkin's LymphomaWithdrawnNCT00389506Not applicable
- A Phase II Study of Temozolomide and O6-Benzylguanine (O6-BG) in Patients With Temozolomide-Resistant Anaplastic GliomaTerminatedNCT00389090Phase 2
- A Phase I Study of Bendamustine Hydrochloride in Patients With Indolent B-cell Non-Hodgkin's LymphomaCompletedNCT00389051Phase 1
- Velcade-Melphalan-Prednisone in Older Untreated Multiple Myeloma Patients.CompletedNCT00388635Phase 1/2
- Temozolomide + Everolimus in Newly Diagnosed, Recurrent, or Progressive Malignant Glioblastoma MultiformeCompletedNCT00387400Phase 1
- Study of Mitomycin-C in Patients With Advanced or Recurrent Pancreatic Cancer With Mutated BRCA2 GeneWithdrawnNCT00386399Phase 2
- QOL-Stereotactic RadioSurgery, Temozolomide + Erlotinib-Rx of 1-3 Brain Metastases in NSCLCWithdrawnNCT00385398Phase 2
- Randomized Trial of ATN-224 and Temozolomide in Advanced MelanomaStatus unknownNCT00383851Phase 2
- Epirubicin and Cyclophosphamide Followed By Docetaxel and Trastuzumab in Treating Women With HER2-Positive Stage III or Stage IV Breast CancerCompletedNCT00379015Phase 2
- Umbilical Cord Blood T-Regulatory Cell Infusion Followed by Donor Umbilical Cord Blood Transplant in Treating Patients With High-Risk Leukemia or Other Hematologic DiseasesTerminatedNCT00376519Phase 1
- Laboratory-Treated Lymphocyte Infusion After Haploidentical Donor Stem Cell TransplantCompletedNCT00376480Phase 1
- Radiation Boost for Newly Diagnosed Glioblastoma MultiformeTerminatedNCT00376103Phase 1/2
- Phase II Study of Temozolomide in Newly Diagnosed GlioblastomaTerminatedNCT00365222Phase 2
- Temozolomide in Patients With Newly Diagnosed Anaplastic Oligodendroglioma and Mixed OligoastrocytomaCompletedNCT00362570Phase 2
- Cisplatin and Temozolomide in Treating Young Patients With Malignant GliomaStatus unknownNCT00360945Phase 2
- Cyclophosphamide Plus T-Cell Transplantation for Patients With Hematologic MalignanciesTerminatedNCT00356928Phase 1
- Imatinib in Combination With Dacarbazine and Capecitabine in Medullary Thyroid CarcinomaTerminatedNCT00354523Phase 1/2
- Cyclophosphamide, Antithymocyte Globulin, and Total-Body Irradiation in Treating Patients With Severe Aplastic Anemia Undergoing Umbilical Cord Blood TransplantTerminatedNCT00354419Phase 1
- Imatinib Mesylate and Temozolomide in Treating Patients With Malignant GliomaCompletedNCT00354068Phase 1
- Primary Chemotherapy With Adriamycin/Cyclophosphamide(AC) vs Taxotere/Xeloda(TX) for Stage II and III Breast CancerCompletedNCT00352378Phase 3
- Outcomes of Intraoperative 5-Fluorouracil Versus Mitomycin CCompletedNCT00346489Phase 4
- Fludarabine and Busulfan Followed by Donor Peripheral Stem Cell Transplant and Antithymocyte Globulin, Tacrolimus, and Methotrexate in Treating Patients With Myeloid CancerCompletedNCT00346359Phase 2
- Intensive Versus Conventional Treatment in Patients With Primary AmyloidosisCompletedNCT00344526Phase 3
- A Pilot Study to Evaluate the Co-Infusion of Ex Vivo Expanded Cord Blood Cells With an Unmanipulated Cord Blood Unit in Patients Undergoing Cord Blood Transplant for Hematologic MalignanciesCompletedNCT00343798Phase 1
- Cyclophosphamide and Rituximab Followed By Vaccine Therapy in Treating Patients With Chronic Lymphocytic LeukemiaWithdrawnNCT00343447Phase 2
- EpSSG (European Soft Tissue Sarcoma Study Group) Protocol for Non-Metastatic Rhabdomyosarcoma in ChildrenStatus unknownNCT00339118Phase 4
- Combination Chemotherapy With or Without Rituximab in Treating Patients With Previously Treated Chronic Lymphocytic LeukemiaCompletedNCT00337246Phase 2
- Efficacy and Safety of Temodal vs Semustine in Subjects With Recurrent Glioblastoma or Anaplastic Astrocytoma (Study P03644)CompletedNCT00335075Phase 3
- Doxorubicin Hydrochloride Liposome, Melphalan, and Bortezomib in Treating Patients With Relapsed or Refractory Stage I, Stage II, or Stage III Multiple MyelomaStatus unknownNCT00334932Phase 1/2
- Ifosfamide and Doxorubicin, Radiation Therapy, and/or Surgery in Treating Young Patients With Localized Soft Tissue SarcomaStatus unknownNCT00334854Phase 3
- Respiratory Side Effects of Busulfan High Dose Chemotherapy in a Pediatric PopulationStatus unknownNCT00328029Phase 2
- Hepatic Arterial Infusion With Melphalan Compared With Standard Therapy in Treating Patients With Unresectable Liver Metastases Due to MelanomaCompletedNCT00324727Phase 3
- Tailoring Treatment for B Cell Non-hodgkin's Lymphoma Based on PET Scan Results Mid TreatmentStatus unknownNCT00324467Phase 2
- CHOP and Campath-1H in Previously Untreated Aggressive T/NK-Cell LymphomasCompletedNCT00323323Phase 1
- Cyclophosphamide in Treating Patients Who Are Undergoing a Donor Bone Marrow Transplant for Fanconi's AnemiaCompletedNCT00317876Phase 1
- Bortezomib, Ascorbic Acid, and Melphalan in Treating Patients With Newly Diagnosed Multiple MyelomaCompletedNCT00317811Phase 2
- Total-Body Irradiation and Cyclophosphamide in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer and Other DiseasesCompletedNCT00317785Phase 2
- Sequential vs Upfront Intensified Neoadjuvant Chemotherapy in Patients With Large Resectable or Locally Advanced Breast Cancer.CompletedNCT00314977Phase 3
- Melphalan and Busulfan Followed By Donor Peripheral Stem Cell Transplant, Tacrolimus, and Methotrexate in Treating Patients With Multiple MyelomaCompletedNCT00313625Phase 2
- Thiotepa and Radiation Therapy in Treating Young Patients With Newly Diagnosed Malignant Brain TumorsStatus unknownNCT00313521Phase 2
- Safety Study of Cetuximab, Radiotherapy and Temozolomide in Primary Glioblastoma Multiforme(GERT)Status unknownNCT00311857Phase 1/2
- AZD2171 and Combination Chemotherapy in Treating Women With Locally Advanced Breast CancerCompletedNCT00310089Not applicable
- Randomized Study Comparing Pre- and Postoperative vs. Conventional Adjuvant Treatment in Receptor-negative PatientsCompletedNCT00309569Phase 3
- Randomized Study Comparing CMF and Goserelin + Tamoxifen in Premenopausal Receptor-positive PatientsCompletedNCT00309478Phase 3
- Bevacizumab, Dacarbazine and Interferon-Alfa to Treat Metastatic MelanomaCompletedNCT00308607Phase 2
- Treatment of Necrotizing Vasculitides for Patients Older Than 65 YearsCompletedNCT00307671Phase 4
- Lenalidomide and Melphalan in Treating Patients With Previously Untreated Multiple MyelomaCompletedNCT00305812Phase 2
- Busulfan, Antithymocyte Globulin, and Fludarabine Followed By a Donor Stem Cell Transplant in Treating Young Patients With Blood Disorders, Bone Marrow Disorders, Chronic Myelogenous Leukemia in First Chronic Phase, or Acute Myeloid Leukemia in First RemissionCompletedNCT00305708Phase 1/2
- Temodar and Sutent as Therapy for MelanomaTerminatedNCT00304200Phase 1/2
- Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic CancerCompletedNCT00304018Phase 1
- Talabostat Combined With Temozolomide or Carboplatin in Treating Young Patients With Relapsed or Refractory Brain Tumors or Other Solid TumorsCompletedNCT00303940Phase 1
- Carboplatin, Melphalan, Etoposide Phosphate, Mannitol, and Sodium Thiosulfate in Treating Patients With Previously Treated Brain TumorsCompletedNCT00303849Phase 1/2
- Low-Dose Fludarabine, Busulfan, and Anti-Thymocyte Globulin Followed By Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic CancerCompletedNCT00301951Phase 1
- Combination Chemotherapy in Treating Patients With Early Stage Breast Cancer That Has Been Removed By SurgeryStatus unknownNCT00301925Phase 3
- Busulfan and Fludarabine Before Donor Stem Cell Transplant in Treating Patients With Hematologic CancerWithdrawnNCT00301912Phase 2
- Phase II High-Dose Cyclophosphamide for Multiple SclerosisWithdrawnNCT00296205Phase 2
- Donor Stem Cell Transplant in Treating Older or Frail Patients With Hematologic CancerCompletedNCT00296023Not applicable
- Donor Stem Cell Transplant in Treating Young Patients With Myelodysplastic Syndrome, Leukemia, Bone Marrow Failure Syndrome, or Severe Immunodeficiency DiseaseCompletedNCT00295971Phase 1
- The MAX Study: Mitomycin C, Avastin and Xeloda in Patients With Untreated Metastatic Colorectal CancerCompletedNCT00294359Phase 2/3
- Clofarabine and Cyclophosphamide in Treating Patients With Relapsed or Refractory Acute Leukemia, Chronic Myelogenous Leukemia, or Myeloproliferative DisordersCompletedNCT00293410Phase 1
- Lomustine in Treating Patients With Stage III or Stage IV Non-Small Cell Lung CancerCompletedNCT00293280Phase 2
- Chemotherapy and Total-Body Irradiation Followed by Donor Umbilical Cord Blood Transplant, Cyclosporine, and Mycophenolate Mofetil in Treating Patients With Hematologic CancerCompletedNCT00290641Not applicable
- TLC D-99 and Ifosfamide in Metastatic Soft Tissue Sarcoma PatientsCompletedNCT00289809Phase 1/2
- Study With Mitomycin c/5-FU/FA in Pretreated Gastrointestinal Cancer Patients With Metastases (>= Second-line Treatment)CompletedNCT00289445Phase 1/2
- Treatment of Mantle Cell Lymphoma at Diagnosis for Patients Under 65 YearsCompletedNCT00285389Phase 2
- Aranesp and Neulasta in Patients With Sarcoma Receiving Adriamycin and IfosfamideCompletedNCT00283621Not applicable
- Radiation With Concomitant and Then Sequential Temozolomide in Malignant GliomaStatus unknownNCT00283543Phase 2
- Fludarabine and Cyclophosphamide in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Chronic Lymphocytic Leukemia or Waldenstrom's MacroglobulinemiaCompletedNCT00281983Phase 1/2
- Fludarabine, Cyclophosphamide, and Rituximab in Treating Patients With Prolymphocytic LeukemiaTerminatedNCT00281931Phase 2
- Rituximab and Combination Chemotherapy in Treating Patients With Non-Hodgkin's LymphomaCompletedNCT00278421Phase 3
- Fludarabine With or Without Cyclophosphamide in Treating Patients With Advanced Chronic Lymphocytic LeukemiaCompletedNCT00276848Phase 3
- Temozolomide in Treating Young Patients With High-Risk Relapsed or Refractory NeuroblastomaCompletedNCT00276679Phase 2
- Arsenic Trioxide, Temozolomide, and Radiation Therapy in Treating Patients With Malignant Glioma That Has Been Removed By SurgeryStatus unknownNCT00275067Phase 1/2
- Rituximab, Fludarabine, and Cyclophosphamide or Observation Alone in Treating Patients With Stage 0, Stage I, or Stage II Chronic Lymphocytic LeukemiaCompletedNCT00275054Phase 3
- Cyclophosphamide and Total Body Irradiation in Treating Patients Who Are Undergoing an Autologous Peripheral Stem Cell Transplant For Chronic Lymphocytic LeukemiaCompletedNCT00275015Phase 2
- Bendamustine and Rituximab in Treating Patients With Previously Untreated or Relapsed Chronic Lymphocytic LeukemiaCompletedNCT00274989Phase 2
- Bendamustine and Mitoxantrone in Treating Patients With Relapsed or Refractory Chronic Lymphocytic LeukemiaCompletedNCT00274963Phase 2
- Radiation Therapy, Temozolomide, and Erlotinib in Treating Patients With Newly Diagnosed Glioblastoma MultiformeCompletedNCT00274833Phase 2
- Comparison Study of WBRT and SRS Alone Versus With Temozolomide or Erlotinib in Patients With Brain Metastases of NSCLCStatus unknownNCT00268684Phase 3
- Mitomycin as a Hyperthermic Peritoneal Perfusion in Treating Patients With Malignant AscitesTerminatedNCT00265863Phase 2
- HD11 for Intermediate StagesCompletedNCT00264953Phase 3